Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Basic Cardiovascular Sciences Scientific Sessions 2019: Integrative Approaches to Complex Cardiovascular Diseases.

Vagnozzi RJ, Pfleger J, Sadayappan S.

Circ Res. 2019 Oct 25;125(10):924-931. doi: 10.1161/CIRCRESAHA.119.315977. Epub 2019 Oct 24. No abstract available.

PMID:
31647770
2.

CARdiac Immunotherapy: T Cells Engineered to Treat the Fibrotic Heart.

Vagnozzi RJ, Johansen AKZ, Molkentin JD.

Mol Ther. 2019 Nov 6;27(11):1869-1871. doi: 10.1016/j.ymthe.2019.09.021. Epub 2019 Oct 1. No abstract available.

PMID:
31585799
3.

Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart

Khalil H, Kanisicak O, Vagnozzi RJ, Johansen AK, Maliken BD, Prasad V, Boyer JG, Brody MJ, Schips T, Kilian KK, Correll RN, Kawasaki K, Nagata K, Molkentin JD.

JCI Insight. 2019 Aug 8;4(15):e128722. doi: 10.1172/jci.insight.128722.

4.

Genetic Lineage Tracing of Sca-1+ Cells Reveals Endothelial but Not Myogenic Contribution to the Murine Heart.

Vagnozzi RJ, Sargent MA, Lin SJ, Palpant NJ, Murry CE, Molkentin JD.

Circulation. 2018 Dec 18;138(25):2931-2939. doi: 10.1161/CIRCULATIONAHA.118.035210. Erratum in: Circulation. 2018 Oct 9;138(15):e424.

5.

New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications.

Vagnozzi RJ, Molkentin JD, Houser SR.

Circ Res. 2018 Jul 6;123(2):159-176. doi: 10.1161/CIRCRESAHA.118.311208. Review.

6.

Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart.

Fu X, Khalil H, Kanisicak O, Boyer JG, Vagnozzi RJ, Maliken BD, Sargent MA, Prasad V, Valiente-Alandi I, Blaxall BC, Molkentin JD.

J Clin Invest. 2018 May 1;128(5):2127-2143. doi: 10.1172/JCI98215. Epub 2018 Apr 16.

7.

van Berlo et al. reply.

van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SJ, Middleton RC, Marbán E, Molkentin JD.

Nature. 2018 Mar 21;555(7697):E18. doi: 10.1038/nature25772. No abstract available.

PMID:
29565361
8.

Identity Crisis for Regenerative Cardiac cKit+ Cells.

Kanisicak O, Vagnozzi RJ, Molkentin JD.

Circ Res. 2017 Oct 27;121(10):1130-1132. doi: 10.1161/CIRCRESAHA.117.311921. Review. No abstract available.

9.

Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.

Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, Vagnozzi RJ, Liu R, Huynh T, Lee SJ, Karch J, Molkentin JD.

J Clin Invest. 2017 Oct 2;127(10):3770-3783. doi: 10.1172/JCI94753. Epub 2017 Sep 11.

10.

In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.

Mitani Y, Vagnozzi RJ, Millay DP.

FASEB J. 2017 Jan;31(1):400-411. doi: 10.1096/fj.201600945R. Epub 2016 Oct 17.

11.

Acute Catecholamine Exposure Causes Reversible Myocyte Injury Without Cardiac Regeneration.

Wallner M, Duran JM, Mohsin S, Troupes CD, Vanhoutte D, Borghetti G, Vagnozzi RJ, Gross P, Yu D, Trappanese DM, Kubo H, Toib A, Sharp TE 3rd, Harper SC, Volkert MA, Starosta T, Feldsott EA, Berretta RM, Wang T, Barbe MF, Molkentin JD, Houser SR.

Circ Res. 2016 Sep 16;119(7):865-79. doi: 10.1161/CIRCRESAHA.116.308687. Epub 2016 Jul 26.

12.

DUSP8 Regulates Cardiac Ventricular Remodeling by Altering ERK1/2 Signaling.

Liu R, van Berlo JH, York AJ, Vagnozzi RJ, Maillet M, Molkentin JD.

Circ Res. 2016 Jul 8;119(2):249-60. doi: 10.1161/CIRCRESAHA.115.308238. Epub 2016 May 25.

13.

Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.

Schwanekamp JA, Lorts A, Vagnozzi RJ, Vanhoutte D, Molkentin JD.

Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):60-8. doi: 10.1161/ATVBAHA.115.306397. Epub 2015 Nov 12.

14.

Cardiac-specific deletion of protein phosphatase 1β promotes increased myofilament protein phosphorylation and contractile alterations.

Liu R, Correll RN, Davis J, Vagnozzi RJ, York AJ, Sargent MA, Nairn AC, Molkentin JD.

J Mol Cell Cardiol. 2015 Oct;87:204-13. doi: 10.1016/j.yjmcc.2015.08.018. Epub 2015 Aug 31.

15.

The Mitochondrial Calcium Uniporter Selectively Matches Metabolic Output to Acute Contractile Stress in the Heart.

Kwong JQ, Lu X, Correll RN, Schwanekamp JA, Vagnozzi RJ, Sargent MA, York AJ, Zhang J, Bers DM, Molkentin JD.

Cell Rep. 2015 Jul 7;12(1):15-22. doi: 10.1016/j.celrep.2015.06.002. Epub 2015 Jun 25.

16.

Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.

Ahmad F, Lal H, Zhou J, Vagnozzi RJ, Yu JE, Shang X, Woodgett JR, Gao E, Force T.

J Am Coll Cardiol. 2014 Aug 19;64(7):696-706. doi: 10.1016/j.jacc.2014.04.068.

17.

Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.

Lal H, Ahmad F, Zhou J, Yu JE, Vagnozzi RJ, Guo Y, Yu D, Tsai EJ, Woodgett J, Gao E, Force T.

Circulation. 2014 Jul 29;130(5):419-30. doi: 10.1161/CIRCULATIONAHA.113.008364. Epub 2014 Jun 4.

18.

c-kit+ cells minimally contribute cardiomyocytes to the heart.

van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SC, Middleton RC, Marbán E, Molkentin JD.

Nature. 2014 May 15;509(7500):337-41. doi: 10.1038/nature13309. Epub 2014 May 7.

19.

Orientation of actin filaments in teleost retinal pigment epithelial cells, and the effect of the lectin, Concanavalin A, on melanosome motility.

King-Smith C, Vagnozzi RJ, Fischer NE, Gannon P, Gunnam S.

Vis Neurosci. 2014 Jan;31(1):1-10. doi: 10.1017/S0952523813000618.

PMID:
24801619
20.

Sorafenib cardiotoxicity increases mortality after myocardial infarction.

Duran JM, Makarewich CA, Trappanese D, Gross P, Husain S, Dunn J, Lal H, Sharp TE, Starosta T, Vagnozzi RJ, Berretta RM, Barbe M, Yu D, Gao E, Kubo H, Force T, Houser SR.

Circ Res. 2014 May 23;114(11):1700-1712. doi: 10.1161/CIRCRESAHA.114.303200. Epub 2014 Apr 9.

21.

MICU1 motifs define mitochondrial calcium uniporter binding and activity.

Hoffman NE, Chandramoorthy HC, Shamugapriya S, Zhang X, Rajan S, Mallilankaraman K, Gandhirajan RK, Vagnozzi RJ, Ferrer LM, Sreekrishnanilayam K, Natarajaseenivasan K, Vallem S, Force T, Choi ET, Cheung JY, Madesh M.

Cell Rep. 2013 Dec 26;5(6):1576-1588. doi: 10.1016/j.celrep.2013.11.026. Epub 2013 Dec 12.

22.

Inhibition of the cardiomyocyte-specific kinase TNNI3K limits oxidative stress, injury, and adverse remodeling in the ischemic heart.

Vagnozzi RJ, Gatto GJ Jr, Kallander LS, Hoffman NE, Mallilankaraman K, Ballard VL, Lawhorn BG, Stoy P, Philp J, Graves AP, Naito Y, Lepore JJ, Gao E, Madesh M, Force T.

Sci Transl Med. 2013 Oct 16;5(207):207ra141. doi: 10.1126/scitranslmed.3006479.

23.

GSK-3α is a central regulator of age-related pathologies in mice.

Zhou J, Freeman TA, Ahmad F, Shang X, Mangano E, Gao E, Farber J, Wang Y, Ma XL, Woodgett J, Vagnozzi RJ, Lal H, Force T.

J Clin Invest. 2013 Apr;123(4):1821-32. doi: 10.1172/JCI64398. Epub 2013 Mar 15.

24.

Protein Kinase Signaling at the Crossroads of Myocyte Life and Death in Ischemic Heart Disease.

Vagnozzi RJ, Hoffman NE, Elrod JW, Madesh M, Force T.

Drug Discov Today Ther Strateg. 2012;9(4):e173-e182.

25.

Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.

Lal H, Zhou J, Ahmad F, Zaka R, Vagnozzi RJ, Decaul M, Woodgett J, Gao E, Force T.

Circulation. 2012 Jan 3;125(1):65-75. doi: 10.1161/CIRCULATIONAHA.111.050666. Epub 2011 Nov 15.

26.

Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice.

Elrod JW, Wong R, Mishra S, Vagnozzi RJ, Sakthievel B, Goonasekera SA, Karch J, Gabel S, Farber J, Force T, Brown JH, Murphy E, Molkentin JD.

J Clin Invest. 2010 Oct;120(10):3680-7. doi: 10.1172/JCI43171. Epub 2010 Sep 20.

Supplemental Content

Loading ...
Support Center